Abstract: Present invention provides a monoclonal antibody binding to Neisseria bacteria and its target antigen Ag473, which include the sequences of its polynucleotide and its amino acid, wherein the Neisseria bacteria can be Neisseria meningitidis or Neisseria gonorrhoeae; and wherein Ag473 can be made into a vaccine or a diagnostic or therapeutic reagent.
Type:
Grant
Filed:
June 16, 2004
Date of Patent:
April 15, 2008
Assignee:
Center of Disease Control Department of Health